Titre : Cellules spumeuses

Cellules spumeuses : Questions médicales fréquentes

Termes MeSH sélectionnés :

Language Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules spumeuses : Questions médicales les plus fréquentes", "headline": "Cellules spumeuses : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules spumeuses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-24", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules spumeuses" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Macrophages", "url": "https://questionsmedicales.fr/mesh/D008264", "about": { "@type": "MedicalCondition", "name": "Macrophages", "code": { "@type": "MedicalCode", "code": "D008264", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.680.397" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules spumeuses", "alternateName": "Foam Cells", "code": { "@type": "MedicalCode", "code": "D005487", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Maria Kurańska", "url": "https://questionsmedicales.fr/author/Maria%20Kura%C5%84ska", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland." } }, { "@type": "Person", "name": "Aleksander Prociak", "url": "https://questionsmedicales.fr/author/Aleksander%20Prociak", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland." } }, { "@type": "Person", "name": "Aniket Raje", "url": "https://questionsmedicales.fr/author/Aniket%20Raje", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } }, { "@type": "Person", "name": "Joachim Koll", "url": "https://questionsmedicales.fr/author/Joachim%20Koll", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } }, { "@type": "Person", "name": "Jelena Lillepärg", "url": "https://questionsmedicales.fr/author/Jelena%20Lillep%C3%A4rg", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Establishing severity levels for patient-reported measures of functional communication, participation, and perceived cognitive function for adults with acquired cognitive and language disorders.", "datePublished": "2022-12-27", "url": "https://questionsmedicales.fr/article/36572789", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11136-022-03337-2" } }, { "@type": "ScholarlyArticle", "name": "Automation of Language Sample Analysis.", "datePublished": "2023-06-22", "url": "https://questionsmedicales.fr/article/37348510", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_JSLHR-22-00642" } }, { "@type": "ScholarlyArticle", "name": "Systematic language input improved productions of elaborated verb phrases of Cantonese-speaking children with language difficulties.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36592049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/02699206.2022.2157330" } }, { "@type": "ScholarlyArticle", "name": "Differences in Child Language Assessment Practices Between School-Based and Non-School-Based Speech-Language Pathologists: Results From a Nationwide Survey.", "datePublished": "2023-09-19", "url": "https://questionsmedicales.fr/article/37725559", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_LSHSS-22-00185" } }, { "@type": "ScholarlyArticle", "name": "Language production impairments in patients with a first episode of psychosis.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35951619", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0272873" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Phagocytes", "item": "https://questionsmedicales.fr/mesh/D010586" }, { "@type": "ListItem", "position": 5, "name": "Macrophages", "item": "https://questionsmedicales.fr/mesh/D008264" }, { "@type": "ListItem", "position": 6, "name": "Cellules spumeuses", "item": "https://questionsmedicales.fr/mesh/D005487" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules spumeuses - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules spumeuses", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules spumeuses", "description": "Comment diagnostique-t-on les cellules spumeuses ?\nQuels tests sont utilisés pour détecter les cellules spumeuses ?\nLes cellules spumeuses sont-elles visibles à l'échographie ?\nQuel rôle joue la biopsie dans le diagnostic ?\nPeut-on détecter les cellules spumeuses par analyse sanguine ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Language+Disorders&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules spumeuses", "description": "Quels symptômes sont associés aux cellules spumeuses ?\nLes cellules spumeuses causent-elles des douleurs ?\nComment les cellules spumeuses affectent-elles la circulation ?\nY a-t-il des signes cliniques visibles ?\nLes cellules spumeuses sont-elles liées à des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Language+Disorders&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules spumeuses", "description": "Comment prévenir la formation de cellules spumeuses ?\nLe tabagisme influence-t-il les cellules spumeuses ?\nLe stress a-t-il un impact sur les cellules spumeuses ?\nUne alimentation riche en graisses est-elle risquée ?\nL'exercice régulier aide-t-il à prévenir les cellules spumeuses ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Language+Disorders&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules spumeuses", "description": "Quels traitements ciblent les cellules spumeuses ?\nLes statines aident-elles contre les cellules spumeuses ?\nY a-t-il des traitements non médicamenteux ?\nLes interventions chirurgicales sont-elles nécessaires ?\nLes traitements naturels sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Language+Disorders&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules spumeuses", "description": "Quelles complications sont liées aux cellules spumeuses ?\nLes cellules spumeuses augmentent-elles le risque d'AVC ?\nPeuvent-elles causer des douleurs thoraciques ?\nLes cellules spumeuses sont-elles réversibles ?\nY a-t-il des risques de rupture de plaque ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Language+Disorders&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules spumeuses", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la formation de cellules spumeuses ?\nLe cholestérol élevé est-il un facteur de risque ?\nLe diabète affecte-t-il la santé vasculaire ?\nLe manque d'exercice est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Language+Disorders&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on les cellules spumeuses ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'analyse histologique des tissus vasculaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les cellules spumeuses ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des biopsies et des examens d'imagerie comme l'IRM peuvent être utilisés." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles visibles à l'échographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont généralement pas visibles à l'échographie standard." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet d'observer la présence de cellules spumeuses dans les plaques." } }, { "@type": "Question", "name": "Peut-on détecter les cellules spumeuses par analyse sanguine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement détectées dans les tissus, pas dans le sang." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux cellules spumeuses ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules spumeuses elles-mêmes ne provoquent pas de symptômes directs." } }, { "@type": "Question", "name": "Les cellules spumeuses causent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne causent pas de douleurs, mais contribuent à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les cellules spumeuses affectent-elles la circulation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent obstruer les vaisseaux sanguins, entraînant des problèmes circulatoires." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, les cellules spumeuses ne présentent pas de signes cliniques visibles." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles liées à des maladies spécifiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent associées à l'athérosclérose et aux maladies cardiaques." } }, { "@type": "Question", "name": "Comment prévenir la formation de cellules spumeuses ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les cellules spumeuses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de formation de cellules spumeuses et d'athérosclérose." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les cellules spumeuses ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut contribuer à des maladies cardiovasculaires, y compris les cellules spumeuses." } }, { "@type": "Question", "name": "Une alimentation riche en graisses est-elle risquée ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées favorise la formation de cellules spumeuses." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir les cellules spumeuses ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la santé cardiovasculaire et réduit les risques." } }, { "@type": "Question", "name": "Quels traitements ciblent les cellules spumeuses ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements visent à réduire le cholestérol et à prévenir l'athérosclérose." } }, { "@type": "Question", "name": "Les statines aident-elles contre les cellules spumeuses ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les statines réduisent le cholestérol et limitent la formation de cellules spumeuses." } }, { "@type": "Question", "name": "Y a-t-il des traitements non médicamenteux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et l'exercice physique peuvent aider à prévenir leur formation." } }, { "@type": "Question", "name": "Les interventions chirurgicales sont-elles nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être nécessaires en cas de complications graves, comme une occlusion." } }, { "@type": "Question", "name": "Les traitements naturels sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certains compléments peuvent aider, mais leur efficacité n'est pas prouvée scientifiquement." } }, { "@type": "Question", "name": "Quelles complications sont liées aux cellules spumeuses ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des maladies cardiovasculaires graves, comme l'infarctus." } }, { "@type": "Question", "name": "Les cellules spumeuses augmentent-elles le risque d'AVC ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent contribuer à l'athérosclérose, augmentant le risque d'AVC." } }, { "@type": "Question", "name": "Peuvent-elles causer des douleurs thoraciques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en provoquant des maladies cardiaques qui peuvent entraîner des douleurs." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une fois formées, elles ne sont pas réversibles, mais leur progression peut être contrôlée." } }, { "@type": "Question", "name": "Y a-t-il des risques de rupture de plaque ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cellules spumeuses peuvent contribuer à la rupture de plaques athéroscléreuses." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'obésité." } }, { "@type": "Question", "name": "L'âge influence-t-il la formation de cellules spumeuses ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de l'accumulation de lipides." } }, { "@type": "Question", "name": "Le cholestérol élevé est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un taux de cholestérol élevé favorise la formation de cellules spumeuses." } }, { "@type": "Question", "name": "Le diabète affecte-t-il la santé vasculaire ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque de maladies cardiovasculaires et de cellules spumeuses." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire augmente le risque de formation de cellules spumeuses." } } ] } ] }

Sources (10000 au total)

Establishing severity levels for patient-reported measures of functional communication, participation, and perceived cognitive function for adults with acquired cognitive and language disorders.

To empirically assign severity levels (e.g., mild, moderate) to four relatively new patient-reported outcome measures (PROMs) for adults with acquired cognitive/language disorders. They include the Co... We conducted 17 focus groups that comprised 22 adults with an acquired cognitive/language disorder from stroke, Parkinson's disease, or traumatic brain injury; 30 care partners of an adult with an acq... There was generally good agreement among the stakeholder groups about how to classify vignettes, particularly when they reflected very high or low functioning. People with aphasia described a larger r... Standardized, stakeholder-informed severity levels that aid interpretation of PROM scores can help clinicians and researchers derive better clinical meaning from those scores, for example, by identify...

Automation of Language Sample Analysis.

A major barrier to the wider use of language sample analysis (LSA) is the fact that transcription is very time intensive. Methods that can reduce the required time and effort could help in promoting t... This article describes an automated pipeline, called Batchalign, that takes raw audio and creates full transcripts in Codes for the Human Analysis of Talk (CHAT) transcription format, complete with ut... For work with recordings from adults with language disorders, six major results were obtained: (a) The word error rate was between 2.4% for controls and 3.4% for patients, (b) utterance tokenization a... The pipeline dramatically shortens the time gap between data collection and data analysis and provides an output superior to that typically generated by human transcribers....

Differences in Child Language Assessment Practices Between School-Based and Non-School-Based Speech-Language Pathologists: Results From a Nationwide Survey.

The purpose of this study was to compare child language assessment practices of speech-language pathologists (SLPs) working in school and nonschool settings to determine if their place of employment i... School-based SLPs (e.g., direct service providers employed in preschool and/or K-12 schools;... Both school-based and non-school-based SLPs reported using a combination of assessment tools when evaluating children with potential language disorders. School-based SLPs tended to rank the frequency ... SLPs practicing in school-based settings seem to handle more employment-based factors that impact independent diagnostic decision making than SLPs working in different employment settings when assessi...

Language patterns in Japanese patients with Alzheimer disease: A machine learning approach.

The authors applied natural language processing and machine learning to explore the disease-related language patterns that warrant objective measures for assessing language ability in Japanese patient... The authors obtained 276 speech samples from 42 patients with AD and 52 healthy controls, aged 50 years or older. A natural language processing library for Python was used, spaCy, with an add-on libra... The model resulted in an accuracy of 0.84 (SD = 0.06), and an area under the curve of 0.90 (SD = 0.03). Among the features that were important for such predictions, seven of the top 10 features were r... The current study demonstrated a promising level of accuracy for predicting AD and found the language patterns corresponding to the type of lexical-semantic decline known as 'empty speech', which is r...

Multidisciplinary Perspectives on Automatic Analysis of Children's Language Samples: Where Do We Go from Here?

Language sample analysis (LSA) is invaluable to describe and understand child language use and development for clinical purposes and research. Digital tools supporting LSA are available, but many of t... To better understand the complexity, challenges, and future needs of automatic LSA from a technological perspective, including the tasks of transcribing, annotating, and analysing natural child langua... Existing tools vary in their extent of automation provided across the process of LSA. Advances in machine learning for speech recognition and processing have potential to facilitate LSA, but the speci...

Syntactic Complexity Across Language Sampling Contexts in School-Age Children, Ages 8-11 Years.

Syntax has been called the structural foundation of language, as its development allows for more efficient and effective communication. Complex syntax production is known to lag in children and adoles... Conversational, narrative, and expository language samples were elicited from 85 children with typically developing language ages 8;0-11;11 (years;months). Samples were transcribed and analyzed for th... Syntactic measures differed significantly across the three sampling contexts. Namely, narrative and expository language samples elicited longer utterances and more syntactically complex language than ... Differences in syntactic measures between conversation and narrative samples and conversation and expository samples within children ages 8-11 years support use of narrative and expository contexts as...

Speech and Language Therapy for Acquired Central Dysgraphia in Neurological Patients: A Systematic Review to Describe and Identify Trainings for Clinical Practice.

Acquired central dysgraphia is a heterogeneous neurological disorder that usually co-occurs with other language disorders. Written language training is relevant to improve everyday skills and as a com... We performed a systematic review of speech and language therapies for acquired dysgraphia in studies of neurological diseases (PROSPERO: CRD42018084221), following the PRISMA (Preferred Reporting Item... Eleven studies of 43 patients in total were included. For each study, we collected data on type of population, type of impairment, experimental design, type of treatment, and measured outcomes. The st... Although there is a need for further experimental evidence, most treatments showed good applicability and improvement of written skills in patients with dysgraphia. Lexical treatments appear to be mor...